« Back to Record
Citation APA

Marty, F. F., Husa, P., Shortino, D., Watson, H. H., Yates, P. P., Peppercorn, A. A., Puigserver, J. V., Clark, C., Gupta, S. S., Merino, E., Garot, D., Chapman, M. M., Jacobs, F., & Rodriguez-Noriega, E. (2017). Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial. The Lancet Respiratory Medicine, 5(2), 135-146. doi:10.1016/S2213-2600(16)30435-0


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/247815

Marty, F. F., Husa, P., Shortino, D., Watson, H. H., Yates, P. P., Peppercorn, A. A., Puigserver, J. V., Clark, C., Gupta, S. S., Merino, E., Garot, D., Chapman, M. M., Jacobs, F., & Rodriguez-Noriega, E. (2017). Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial. The Lancet Respiratory Medicine, 5(2), 135-146. doi:10.1016/S2213-2600(16)30435-0